Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
Inspire Medical Systems (NYSE: INSP) will report fourth quarter and full year 2025 financial results after market close on Wednesday, February 11, 2026.
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) will report fourth quarter and full year 2025 financial results after market close on Wednesday, February 11, 2026. Management will host a conference call at 5:00 p.m. Eastern Time to discuss results and recent business developments.
A live webcast will be available on the company’s Investor Relations page and registration is required to ask questions; registrants receive dial-in details and a unique access code. The company recommends registering at least 10 minutes before the call. A replay will be posted approximately two hours after the event and archived on the Investor Relations site for two weeks.
Positive
- None.
Negative
- None.
Details
News Market Reaction – INSP
On Jan 7, the day this news came out, INSP closed 1.87% above the previous close.
Data tracked by StockTitan Argus for the Jan 7 session.
Key Figures
- Earnings release date
- February 11, 2026
- Scheduled Q4 and full-year 2025 financial results
- Conference call time
- 5:00 p.m. Eastern Time
- Start time for Q4 2025 earnings call
- Replay availability
- Two weeks
- Archived webcast on Investor Relations website
- Replay delay
- Approximately two hours
- Time after event when replay becomes available
- Suggested early registration
- 10 minutes before start
- Recommended buffer to connect to live call
Historical Context
-
J.P. Morgan Healthcare Conference presentation and webcast details.
-
Piper Sandler healthcare conference participation with webcast access.
-
Q3 2025 earnings with revenue growth and raised EPS guidance.
-
UBS Global Healthcare Conference presentation and webcast replay.
-
Inspire V clinical and market data with improved outcomes and safety.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and full year 2025 after the close of trading on Wednesday, February 11. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q4 2025 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.
If you plan to ask a question, please use the following link: Inspire's Q4 2025 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.
Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.